OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Pontus Forsell

1 Projects | 1 Researchers | $456,905 Invested

2015

AlzeCure Pharma AB

Pontus Forsell, PhD

NeuroRestore - development of positive allosteric modulators of TrkA and TrkB

  • Funding Amount: $456,905
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed